Evidence map›Paper›PMID 34406838›Full record

ArticleMicrobiology spectrum2021

Saliva is Comparable to Nasopharyngeal Swabs for Molecular Detection of SARS-CoV-2.

Cody Callahan, Sarah Ditelberg, Sanjucta Dutta, Nancy Littlehale, Annie Cheng, Kristin Kupczewski, Danielle McVay, Stefan Riedel, James E Kirby, Ramy Arnaout

Abstract read
In one paragraph

Article in Microbiology spectrum, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Viruses · 2024
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Saliva diagnostics: Salivaomics, saliva exosomics, and saliva liquid biopsy.Journal of the American Dental Association (1939) · 2023
    Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Validation of RT-qPCR test for SARS-CoV-2 in saliva specimens.Journal of infection and public health · 2022
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Cody CallahanDepartment of Radiology, Beth Israel Deaconess Medical Centergrid.239395.7, Boston, Massachusetts, USA.
Sarah DitelbergDepartment of Pathology, Beth Israel Deaconess Medical Centergrid.239395.7, Boston, Massachusetts, USA.
Sanjucta DuttaDepartment of Pathology, Beth Israel Deaconess Medical Centergrid.239395.7, Boston, Massachusetts, USA.
Nancy LittlehaleBeth Israel Deaconess Medical Centergrid.239395.7, Boston, Massachusetts, USA.
Annie ChengDepartment of Pathology, Beth Israel Deaconess Medical Centergrid.239395.7, Boston, Massachusetts, USA.
Kristin KupczewskiDepartment of Pathology, Beth Israel Deaconess Medical Centergrid.239395.7, Boston, Massachusetts, USA.
Danielle McVayDepartment of Pathology, Beth Israel Deaconess Medical Centergrid.239395.7, Boston, Massachusetts, USA.
Stefan RiedelDepartment of Pathology, Beth Israel Deaconess Medical Centergrid.239395.7, Boston, Massachusetts, USA.ORCID 0000-0002-0573-4957
James E KirbyDepartment of Pathology, Beth Israel Deaconess Medical Centergrid.239395.7, Boston, Massachusetts, USA.ORCID 0000-0003-0392-4500
Ramy ArnaoutDepartment of Pathology, Beth Israel Deaconess Medical Centergrid.239395.7, Boston, Massachusetts, USA.ORCID 0000-0001-6955-9310

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The continued need for molecular testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the potential for self-collected saliva as an alternative to nasopharyngeal (NP) swabs for sample acquisition led us to compare saliva to NP swabs in an outpatient setting without restrictions to avoid food, drink, smoking, or tooth-brushing. A total of 385 pairs of NP and saliva specimens were obtained, the majority from individuals presenting for initial evaluation, and were tested on two high-sensitivity reverse transcriptase PCR (RT-PCR) platforms, the Abbott m2000 and Abbott Alinity m (both with limits of detection [LoD] of 100 copies of viral RNA/ml). Concordance between saliva and NP swabs was excellent overall (Cohen's κ = 0.93) for both initial and follow-up testing, for both platforms, and for specimens treated with guanidinium transport medium as preservative as well as for untreated saliva (κ = 0.88 to 0.95). Viral loads were on average 16× higher in NP specimens than saliva specimens, suggesting that only the relatively small fraction of outpatients (∼8% in this study) who present with very low viral loads (<1,600 copies/ml from NP swabs) would be missed by testing saliva instead of NP swabs when using sensitive testing platforms. Special attention was necessary to ensure leak-resistant specimen collection and transport. The advantages of self-collection of saliva, without behavioral restrictions, will likely outweigh a minor potential decrease in clinical sensitivity in individuals less likely to pose an infectious risk to others for many real-world scenarios, especially for initial testing.

Indexed as

COVID-19COVID-19 Nucleic Acid TestingDiagnostic Tests, RoutineHumansLimit of DetectionNasopharynxPolymerase Chain ReactionRNA, ViralSalivaSARS-CoV-2Sensitivity and SpecificitySpecimen HandlingTimeViral LoadRNA, ViralCOVID-19limit of detectionNP swabsalivaSARS-CoV-2

Identifiers

PMID34406838
PMCPMC8552668

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.